Johnson & Johnson launched a new late-stage trial in Britain to test a two-dose regimen of the company’s experimental Covid-19 vaccine among thousands of volunteers, as the U.S. drugmaker’s clinical studies expand by geography and type.

Moderna is projected to have data to report by the end of November on the company’s Covid-19 vaccine program.

Ugur Sahin, founder and chief executive officer of Germany-based BioNTech, sees the potent efficacy of BNT162b2 – the vaccine developed by his company and partner Pfizer – as the possible “beginning of the end” of the coronavirus pandemic.

Russia’s Sputnik V vaccine is 92% effective at protecting people from Covid-19 according to interim trial results, the country’s sovereign wealth fund said, as Moscow rushes to keep pace with Western drugmakers in the race for a shot.

Pfizer received positive top-line results from the Phase III JADE REGIMEN study, examining the investigational oral once-daily Janus kinase 1 (JAK1) inhibitor abrocitinib for the treatment of severe atopic dermatitis.

U.S. Health Secretary Alex Azar said if pharmaceutical company Pfizer Inc. submits interim Covid-19 vaccine to health regulators as quickly as expected, the U.S. government anticipates the beginning of vaccinating Americans in December.

There were more than 59,000 Covid-19 patients in hospitals across the United States on Nov. 9, the country’s highest number ever of in-patients being treated for the disease, with new infections at record levels for the sixth consecutive day.

Novavax Inc. is on track to begin a delayed U.S.-based, late-stage study of the company’s experimental coronavirus vaccine during November

Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, greeted news about the vaccine against the deadly coronavirus that Pfizer Inc. is developing as “a big deal” and said the United States could have vaccine doses ready to administer to people before the end of 2020.

Pfizer Inc.’s experimental Covid-19 vaccine was more than 90% effective based on initial trial results, the company said, a major victory in the fight against a pandemic that has killed more than 1 million people and battered the world’s economy.